Rumored Buzz on Healthcare News
FTC sues key pharmacy reward managers around insulin selling prices The agency brought motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of existence-saving insulin drugs.Wherever are the many nurses? Hospitals, advocates disagree on di